The Gross Margin of Cytodyn Inc (CYDY) is
-27547.74%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date |
Value |
| 2025-05-31 |
-27547.74%
|
| 2024-05-31 |
-27547.74%
|
| Ticker |
Name |
Value |
|
KROS
|
Keros Therapeutics, Inc.
|
7775.20%
|
|
NKTX
|
Nkarta, Inc.
|
7775.20%
|
|
STTK
|
Shattuck Labs Inc
|
7775.20%
|
|
NWBO
|
Northwest Biotherapeutics Inc
|
100.00%
|
|
STOK
|
Stoke Therapeutics, Inc.
|
7775.20%
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
90.24%
|
|
PCVX
|
Vaxcyte, Inc.
|
7775.20%
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
7775.20%
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
95.96%
|
|
AKRO
|
Akero Therapeutics Inc
|
7775.20%
|
|
ANNX
|
Annexon, Inc.
|
7775.20%
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
82.44%
|
|
FDMT
|
4D Molecular Therapeutics Inc
|
7775.20%
|
|
QURE
|
uniQure N.V.
|
89.53%
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
82.89%
|
|
CMPS
|
Compass Pathways PLC
|
7775.20%
|
|
IMVT
|
Immunovant, Inc.
|
7775.20%
|
|
KRON
|
Kronos Bio LLC
|
7775.20%
|
|
KRYS
|
Krystal Biotech, Inc.
|
94.08%
|
|
PASG
|
Passage Bio Inc
|
7775.20%
|
|
ITOS
|
iTeos Therapeutics Inc
|
7775.20%
|
|
KNSA
|
Kiniksa Pharmaceuticals International, PLC
|
88.54%
|
|
KNTE
|
Kinnate Biopharma Inc
|
7775.20%
|
|
DVAX
|
Dynavax Technologies Corp
|
82.17%
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
89.73%
|
|
OCGN
|
Ocugen, Inc.
|
7775.20%
|
|
REPL
|
Replimune Group, Inc.
|
7775.20%
|